Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Maker of breast cancer detection system receives $2.1 million additional funding
September 1st, 2005
Infrared Sciences Corporation (ISC) has announced that it has completed a $2.1 million series B preferred stock financing. The capital is to be used to market Sentinel BreastScan. ISC completed a $1 million series A stock financing in October 2004. Utilizing infrared imaging and software using artificial intelligence techniques, Sentinel BreastScan is designed to be used as an adjunctive test with mammography, ultrasound or clinical examination for the early detection of breast cancer. It is an U.S. Food and Drug Administration (FDA)-approved, noninvasive touch less procedure offered to women of any age, to help determine current breast health. The patient sits in a...
Source: Women's Health Weekly (2005-09-01)
|
